Dahlman Rose is out with its report today on Eastman Chemical EMN, raising its PT from $105 to $112.
In a note to clients, Dahlman Rose writes, "We have raised our earnings outlook and our price target to $112/share from $105/share. We believe shares may come under pressure near term due to slower global growth, but should rebound from any setbacks. We see the company effectively managing its raw input costs and generating sustainable earnings growth."
Dahlman Rose maintains Buy on EMN.
At the time of posting, shares of EMN were trading at $101.35, up 0.74% from Wednesday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorPrice TargetAnalyst RatingsDahlman RoseDiversified Chemicalseastman chemicalMaterials
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in